MIF and neoplasm: This discovery extends previous evidence of tumor-derived MIF priming premetastatic niches by uncovering a novel hepatocyte-tumor cell crosstalk.23 Preclinical models validated the pro-metastatic role of MIF, with genetic knockdown or pharmacological inhibition of MIF significantly reducing liver metastasis.